Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMar 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 2, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 2, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 2, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 2, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 2, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 2, 2016View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMar 1, 2016View HTMLDownload DOCDownload PDFDownload XLS
10-KAnnual report which provides a comprehensive overview of the company for the past yearFeb 29, 2016View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
4Statement of changes in beneficial ownership of securitiesFeb 26, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 26, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 26, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 26, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 26, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 26, 2016View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventFeb 25, 2016View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesFeb 23, 2016View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 16, 2016View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 16, 2016View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 12, 2016View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-136

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information